Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (30 ops.)
Latest filing published 27 Jul 2026 for Olema Pharmaceuticals, Inc., €127k. Read the official filing
Filing timeline
BuySaleCyrus Harmon
Insider track record
Disclosed buys
0
Disclosed sells
30
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Cyrus Harmon: trading record in brief
Cyrus Harmon (senior executive) discloses dealings in Olema Pharmaceuticals, Inc. to SEC (Form 4). The record holds 32 filings, for trades running from 18 June 2021 to 24 July 2026.
The open-market record consists of 30 sales worth €4.8M, with no purchase. Outside the open market, there are 2 share grants. 2026 to date brings no purchases and 4 sales.
The latest filing, published on 27 July 2026, reports an open-market sale of €127k in Olema Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cyrus Harmon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
12,500 shares@ US$11.5790.014% mcap2.6% of flowCommon StockSEC:0001831410-26-000008:0
12,500 shares@ US$11.7140.014% mcap2.6% of flowCommon StockSEC:0001831410-26-000008:1
10,000 shares@ US$26.885.1% of flowCommon StockSEC:0001831410-26-000004:0
3,489 shares@ US$29.121.9% of flowCommon StockSEC:0001831410-26-000002:0
2,881 shares@ US$28.531.7% of flowCommon StockSEC:0001831410-25-000007:0
10,000 shares@ US$8.041.6% of flowCommon StockSEC:0001831410-25-000004:0
29,250 shares0Common StockSEC:0001415889-24-029028:0
4,066 shares@ US$15.581.1% of flowCommon StockSEC:0001415889-24-020461:0
5,000 shares@ US$12.261.1% of flowCommon StockSEC:0001415889-24-019528:0
20,000 shares@ US$10.773.9% of flowCommon StockSEC:0001415889-24-018975:0
15,000 shares@ US$9.412.5% of flowCommon StockSEC:0001415889-24-015508:0
5,000 shares@ US$10.921.0% of flowCommon StockSEC:0001415889-24-012485:0
15,000 shares@ US$9.512.6% of flowCommon StockSEC:0001415889-24-012020:0
20,000 shares@ US$10.973.9% of flowCommon StockSEC:0001415889-24-009445:0
24,900 shares@ US$12.415.5% of flowCommon StockSEC:0001415889-24-006322:0
25,000 shares@ US$12.235.4% of flowCommon StockSEC:0001415889-24-002350:0
22,500 shares@ US$13.305.2% of flowCommon StockSEC:0001415889-24-000070:0
25,000 shares@ US$12.575.5% of flowCommon StockSEC:0001415889-23-015701:0
15,750 shares0Common StockSEC:0001415889-23-015457:0
25,000 shares@ US$12.055.5% of flowCommon StockSEC:0001415889-23-014714:0
25,000 shares@ US$12.415.7% of flowCommon StockSEC:0001415889-23-013898:0
15,000 shares@ US$10.142.7% of flowCommon StockSEC:0001415889-23-012898:0
15,000 shares@ US$9.362.5% of flowCommon StockSEC:0001415889-23-012922:0
15,000 shares@ US$10.142.7% of flowCommon StockSEC:0001415889-23-012360:0
10,000 shares@ US$6.301.1% of flowCommon StockSEC:0001415889-23-009522:0
25 of 32 declarations
